Drugs / Alflibercept
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03340610 | Jun 2015 → Dec 2018 | diabetic macular edema | Southeast Retina Center, Georgia | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alflibercept | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03340610 ↗ |
| Route | Intravitreal | “Intravitreal Injection” NCT03340610 ↗ |